News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Cancer Genetics, Inc. Announces Exercise of Underwriters' Over-Allotment Option


9/5/2013 10:00:55 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

RUTHERFORD, N.J., Sept. 5, 2013 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX), an emerging leader in DNA-based cancer diagnostics that personalizes the diagnosis and prediction of treatment outcomes for difficult to diagnose cancers, today announced a partial exercise of the over-allotment option granted to the underwriters to purchase an additional 105,000 shares of common stock at a price of $10.00 per share, bringing the total gross proceeds from the offering to $16,050,000, before underwriting discounts and commissions and other offering expenses payable by Cancer Genetics.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES